The Giordani Group at the interface of computational and experimental design toward the early diagnosis of Alzheimer disease.

ALERT consortium is moving fast towards it aim with a renewed optimism and spirit!
The first technical meeting has concluded and the scenario is clear: the development of multi-analyte devise for minimally invasive Alzheimer’s disease diagnosis is a complex and ambitus task. However, it is in uncertain and challenging fields that researchers thrive, developing the most sophisticated and elegant solutions.
The Giordani Group is actively joining ALERT’s journey to reach the final goal, working at the interface of multidisciplinary expertise; combining computational models and advanced chemical synthesis, and establishing the best conditions for combining fluorescent probes and microneedle formulations.

Every single ALERT member is a worldwide expert in their field, but the real strength of the consortium relies on an often-overlooked skill: communication.
ALERT consortium and Silvia Giordani share the same philosophy. Both are focusing on the discovery process and product translation of the new diagnostic device to benefit the wider of the population. They also underline that this EU-funded project is not a race between groups, but rather a synergy between experts that will provide new knowledge and insights into human health.
To learn more about our research and upcoming milestones, visit the ALERT consortium website (https://www.alert-project.eu/) and or follow the Giordani Group!